Reduced number of circulating endothelial progenitor cells in hypogonadal men

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4599-4602

  Foresta, Carlo ^a   Caretta, N ^a   Lana, A ^a   De Toni, L ^a   Biagioli, A ^a   Ferlin, A ^a   Garolla, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC DISEASE; IMMUNOCYTOCHEMISTRY; LONG TERM CARE; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 33751545958     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0763     Document Type: Article

References (21)

1. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ 2006 Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 290:E234-E242
2. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819
3. Dockery F, Bulpitt CJ, Donaldson M, Fernandez S, Rajkumar C 2003 The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc 51:1627-1632
4. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS 2003 Testosterone as a protective factor against atherosclerosis: immunomodulation and influence upon plaque development and stability. J Endocrinol 178:373-380
5. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica PL, Bonfigli B, Volpe M, Chierchia SL 1999 Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 99:1666-1670
6. Kang SM, Jang Y, Kim JY, Chung N, Cho SY, Chae JS, Lee JH 2002 Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol 89:862-864
7. Verma S, Buchanan MR, Anderson TJ 2003 Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054-2059
8. Verma S, Anderson TJ 2002 Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:546-549
9. Dimmeler S, Zeiher AM 2004 Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82:671-677
10. Garmy-Susini B, Varner JA 2005 Circulating endothelial progenitor cells. Br J Cancer 93:855-858
11. Liu PY, Death AK, Handelsman DJ 2003 Androgens and cardiovascular disease. Endocr Rev 24:313-340
12. Munoz M, Bancroft J, Marshall I 1993 The performance of the RigiScan in the measurement of penile tumescence and rigidity. Int J Impot Res 5:69-76
13. Foresta C, Caretta N, Lana A, Cabrelle A, Palu G, Ferlin A 2005 Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 17:288-290
14. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G 2005 Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007
15. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ 2004 Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199
16. Shabsigh R, Katz M, Yan G, Makhsida N 2005 Cardiovascular issues in hypogonadism and testosterone therapy. 96(Suppl):67M-72M
17. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
18. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
19. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Bohm M, Nickenig G 2003 Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059-3065
20. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
21. Mantalaris A, Panoskaltsis N, Sakai Y, Bourne P, Chang C, Messing EM, Wu JH 2001 Localization of androgen receptor expression in human bone marrow. J Pathol 193:361-366